We are live on ! Find out more
AERI

Aerie Pharmaceuticals
AERI

Delisted

AERI was delisted on the 18th of November, 2022.

Back to rankings

155 hedge funds and large institutions have $712M invested in Aerie Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 55 increasing their positions, 54 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

2% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 54

0% more funds holding

Funds holding: 155 → 155 (0)

0% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 27

1% less capital invested

Capital invested by funds: $716M → $712M (-$4.29M)

56% less call options, than puts

Call options by funds: $572K | Put options by funds: $1.29M

83% less funds holding in top 10

Funds holding in top 10: 6 → 1 (-5)

Holders
155
Holders Change
–
Holders Change %
0%
% of All Funds
3.18%
Holding in Top 10
1
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-83.33%
% of All Funds
0.02%
New
27
Increased
55
Reduced
54
Closed
27
Calls
$572K
Puts
$1.29M
Net Calls
-$723K
Net Calls Change
+$3.83M

Top Buyers

Rank Fund Capital Flow
1
William Blair Investment Management
William Blair Investment Management
Illinois
+$20.3M
2
Citadel Advisors
Citadel Advisors
Florida
+$19.9M
3
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
+$17.5M
4
Bank of America
Bank of America
North Carolina
+$11M
5
Morgan Stanley
Morgan Stanley
New York
+$7.56M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$83.2M
2
DM
Deerfield Management
New York
-$30.1M
3
AllianceBernstein
AllianceBernstein
Tennessee
-$8.71M
4
First Manhattan
First Manhattan
New York
-$7.81M
5
APM
Avidity Partners Management
Texas
-$6.84M
Name Holding Trade Value Shares
Change 		Change in
Stake
AIC
176
Ameritas Investment Company
Nebraska
– -$2K -200 Closed
BBHC
177
Brown Brothers Harriman & Co
New York
– -$2K -170 Closed
WAP
178
Wealthcare Advisory Partners
Pennsylvania
– -$2K -125 Closed
QCG
179
Quadrant Capital Group
Ohio
– -$1K -106 Closed
PFO
180
Pathstone Family Office
New Jersey
– -$1K -70 Closed
4 5 6 7
8

AERI Hedge Fund Activity: Q2 2020 in Review

155 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Aerie Pharmaceuticals (AERI) for Q2 2020, worth a combined $712M — down 0.6% from $716M a quarter earlier.

Fund positioning in AERI was balanced in Q2 2020: 27 funds opened new positions, 27 closed out, 55 added to existing stakes and 54 trimmed.

The largest buyer was William Blair Investment Management, opening a new position worth an estimated $20.3M. The largest seller was Wellington Management Group, cutting an estimated $83.2M.

  • 155 institutional investors held Aerie Pharmaceuticals (AERI) as of Q2 2020, unchanged from Q1 2020.
  • Funds reported $712M of Aerie Pharmaceuticals stock for Q2 2020, down 0.6% quarter-over-quarter.
  • 27 funds opened new Aerie Pharmaceuticals positions in Q2 2020 and 27 closed out, a net change of 0 holders.
  • The largest Aerie Pharmaceuticals buyer in Q2 2020 was William Blair Investment Management, an estimated $20.3M added.
  • The largest Aerie Pharmaceuticals seller in Q2 2020 was Wellington Management Group, an estimated $83.2M sold.

Based on aggregated 13F filings for Q2 2020.